2) chimeric T-cell receptor
嵌合性T细胞受体
1.
Anti-tumor effects of murine T-lymphocytes harboring p185HER2 specific chimeric T-cell receptor gene;
转染嵌合性T细胞受体基因小鼠T淋巴细胞的体外抗肿瘤作用
3) T cell receptor
T细胞受体
1.
Reorientation of T cell receptors during immunological synapse formation:a vortex-driven model;
免疫突触形成过程中T细胞受体的重定向运动:涡旋驱动模型
2.
The specific cytotoxic effect of tumor infiltrating lymphocytes transfected with chimeric T cell receptor on cells which express KDR;
表达嵌合性T细胞受体的肿瘤浸润淋巴细胞对KDR表达阳性细胞的选择性杀伤作用
3.
Analysis of T cell receptor VγI-Jγgene rearrangement in elderly patients with acute leukemia;
老年人急性白血病T细胞受体VγI-Jγ基因重排分析
4) TCR
T细胞受体
1.
Objective To construct a retroviral vector of the chimeric TCR, which comprises scFv-anti-erbB2, CD8 hinge region and CD3ζ by gene engineering technology.
目的利用基因工程技术构建表达嵌合T细胞受体(ch-TCR)分子的逆转录病毒载体(由抗 erbB2的单链抗体和信号传导链CD3ζ组成),感染预先刺激的小鼠T细胞,使得T细胞能以MHC非限制性的方式在体外识别并杀伤肿瘤细胞,为肿瘤的过继性免疫治疗提供新思路。
2.
Objective: To clone human T cell receptor (TCR) ζ chain gene and express its encoding protein by baculoviral expression system in insect cells.
目的 :克隆人T细胞受体 (TCR) ζ链基因 ,运用昆虫杆状病毒系统表达该蛋白。
3.
Method Clinicopathologic study, immunohistochemical staining by LSAB method, TCR β and TCR γ gene rearrangement analysis and detection of EBV DNA by PCR technique, EBER in situ hybridization(ISH) and detection of cell apoptosis by in situ end labeling of fragmented DNA technique were.
方法 :过去 15年中对近 2 0 0例“中线恶网”病例做了一系列研究 ,包括临床病理分析、LSAB法免疫组化染色作免疫表型分析、用PCR技术作T细胞受体β和γ链基因重排及EBV DNA检测、EBER原位杂交和原位末端标记DNA片段技术检测细胞凋亡。
5) T cell receptor (TCR)
T细胞受体
1.
Objective To investigate the expression and clonality of T cell receptor (TCR) Vβ repertoire in cord blood T cells induced by PML-RARα peptide in vitro.
目的了解PMLRARα多肽诱导脐血T细胞的T细胞受体(TCR)Vβ谱系表达和克隆性情况。
6) T-cell receptor
T细胞受体
1.
ObjectiveTo explore the immune pathogenesis of aplastic anemia (AA) and the therapeutic effects of Shengxue Mixture (SM) through the gene expressions of subfamilies of T-cell receptor variable region β (TCR Vβ) using immunologic and molecular biologic technology.
目的利用免疫学和分子生物学技术,着重从T细胞受体β链可变区(TCR Vβ)亚家族基因表达角度探讨再生障碍性贫血(AA)的免疫发病机制及中药复方生血合剂的治疗作用。
补充资料：淋巴细胞膜受体
淋巴细胞膜受体
淋巴细胞膜上接受外来物的受体，如人类T细胞有绵羊红细胞受体，即E受体。B细胞、K细胞和部分T细胞有可与免疫球蛋白的Fc段结合的受体；多数B细胞有C3受体；T细胞、 B细胞有抗原受体、促有丝分裂原受体等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条